BridgeMD
Tests treatment safety and results for Generalized Myasthenia Gravis
Official title Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
ClinicalTrials.gov ID: NCT07039916
What this study is testing
What is IMVT-1402?
IMVT-1402 is an investigational medicine, given as an once-weekly injection under the skin, being studied as a potential treatment for generalized myasthenia gravis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of the study is to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Participants with the ability to understand the requirements of the trial, provide written informed consent, and comply with the trial protocol...
- Have mild to severe gMG by Myasthenia Gravis Foundation of America (MGFA) classification of Class II, III, or IVa at the Screening Visit
- Have an MG activities of daily living (MG-ADL) score of ≥ 6 at the Screening Visit and Baseline Visit (Day 1) Additional are defined in the protocol.
You likely can't join if
- Have experienced myasthenic crisis within 12 weeks prior to the Screening Visit.
- Have had a thymectomy performed \< 6 months prior to the Screening Visit or have a planned thymectomy during the study
- Have any active or untreated malignant thymoma Additional exclusion criteria are defined in the protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Huntsville, Alabama, United States
- Mobile, Alabama, United States
- Phoenix, Arizona, United States
- Scottsdale, Arizona, United States
- Tucson, Arizona, United States
- Carlsbad, California, United States
- Irvine, California, United States
- Los Angeles, California, United States
- Rancho Mirage, California, United States
- San Francisco, California, United States
- Fort Collins, Colorado, United States
- New Haven, Connecticut, United States
- Washington D.C., District of Columbia, United States
- Clearwater, Florida, United States
- Ormond Beach, Florida, United States
- Port Charlotte, Florida, United States
- Rockledge, Florida, United States
- Tampa, Florida, United States
- Atlanta, Georgia, United States
- Augusta, Georgia, United States
+ 56 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Huntsville, Alabama, United States; Mobile, Alabama, United States; Phoenix, Arizona, United States; Scottsdale, Arizona, United States; Tucson, Arizona, United States; Carlsbad, California, United States and 70 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.